Corrigendum
Wang XJ, Wong SH, Givergis R, Chynn EW. Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK. Clin Ophthalmol. 2011;5:1451-1457.On page 1456 the Acknowledgment section details were incomplet...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9e8cc5f836c543cd99d613e62ca1fa01 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9e8cc5f836c543cd99d613e62ca1fa01 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9e8cc5f836c543cd99d613e62ca1fa012021-12-02T02:35:59ZCorrigendum1177-54671177-5483https://doaj.org/article/9e8cc5f836c543cd99d613e62ca1fa012011-10-01T00:00:00Zhttp://www.dovepress.com/-corrigendum--a8566https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Wang XJ, Wong SH, Givergis R, Chynn EW. Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK. Clin Ophthalmol. 2011;5:1451-1457.On page 1456 the Acknowledgment section details were incomplete. The corrected Acknowledgment section is: ISTA Pharmaceuticals Inc provided ketorolac tromethamine ophthalmic solution 0.5% and bromfenac sodium ophthalmic solution 0.09% free of charge for this study and monetary compensation to the subjects to encourage participation. Dalton and Associates provided medical editing expertise.Original ArticleChynn EWGivergis RWong SHWang XJDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 1557-1558 (2011) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Ophthalmology RE1-994 |
spellingShingle |
Ophthalmology RE1-994 Chynn EW Givergis R Wong SH Wang XJ Corrigendum |
description |
Wang XJ, Wong SH, Givergis R, Chynn EW. Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK. Clin Ophthalmol. 2011;5:1451-1457.On page 1456 the Acknowledgment section details were incomplete. The corrected Acknowledgment section is: ISTA Pharmaceuticals Inc provided ketorolac tromethamine ophthalmic solution 0.5% and bromfenac sodium ophthalmic solution 0.09% free of charge for this study and monetary compensation to the subjects to encourage participation. Dalton and Associates provided medical editing expertise.Original Article |
format |
article |
author |
Chynn EW Givergis R Wong SH Wang XJ |
author_facet |
Chynn EW Givergis R Wong SH Wang XJ |
author_sort |
Chynn EW |
title |
Corrigendum |
title_short |
Corrigendum |
title_full |
Corrigendum |
title_fullStr |
Corrigendum |
title_full_unstemmed |
Corrigendum |
title_sort |
corrigendum |
publisher |
Dove Medical Press |
publishDate |
2011 |
url |
https://doaj.org/article/9e8cc5f836c543cd99d613e62ca1fa01 |
work_keys_str_mv |
AT chynnew corrigendum AT givergisr corrigendum AT wongsh corrigendum AT wangxj corrigendum |
_version_ |
1718402365784064000 |